Legal Representation
Attorney
Mark Lerner
USPTO Deadlines
Application History
11 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 9, 2006 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| May 9, 2006 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Oct 8, 2005 | GRML | O | CORRESPONDENCE E-MAILED | Loading... |
| Oct 8, 2005 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Jul 14, 2005 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 8, 2005 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 8, 2005 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 8, 2005 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 8, 2005 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 7, 2005 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 14, 2004 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Vaccines, therapeutic vaccines and therapeutic pharmaceuticals derived from monoclonal antibodies for use in the treatment of cancer
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005